Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat + Idarubicin + Cytarabine in Elderly AML
NCT00840346Phase 2Completed
- Sponsor
- Fundación PETHEMA
- Start
- Sep 2009
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in acute myeloid leukemia (AML), sponsored by Fundación PETHEMA. Started Sep 2009; status: completed.
02
Drugs
panobinostat
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00840346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840346.